RPS6KA1 and cancer: To study the effect of RSK2 on MSP-induced EMT in more detail, two human cancer cell lines L3.6pl and HT-29 were selected based on their differences in RSK1 and RSK2 levels and similarities in RON and TGF-β receptor expression (Figure 6A).